Table of Content

1. Preface
2. Assumptions and Research Methodology
3. Executive Summary: Global Market
4. Market Overview
5. Global Market Analysis and Forecasts, By Drug Class
  5.1. Proton Pump Inhibitors
  5.2. H2 Antagonist
  5.3. Acid Neutralizers
6. Global Market Analysis and Forecasts, By Formulation
  6.1. Tablet 
  6.2. Liquid
  6.3. Powder
  6.4. Others
7. Global Market Analysis and Forecasts, By Distribution Channel
  7.1. Hospital Pharmacies
  7.2. Retail Pharmacies
  7.3. Others
8. Global Market Analysis and Forecasts, By Region
  8.1. North America
  8.2. Europe
  8.3. Asia Pacific
  8.4. Latin America
  8.5. Middle East and Africa
9. North America Market Analysis and Forecast
10. Europe Market Analysis and Forecast
11. Asia Pacific Market Analysis and Forecast
12. Latin America Market Analysis and Forecast
13. Middle East and Africa Market Analysis and Forecast
14. Competition Landscape
  14.1. AstraZeneca
  14.2. Bayer AG
  14.3. Boehringer Ingelheim GmbH
  14.4. Dr. Reddy’s Laboratories Ltd.
  14.5. GlaxoSmithKline plc
  14.6. Johnson & Johnson
  14.7. Pfizer Inc.
  14.8. Procter & Gamble
  14.9. Reckitt Benckiser Group plc
  14.10. Sanofi
  14.11. Sun Pharmaceuticals Ltd
  14.12. Takeda Pharmaceutical
  14.13. Valeant Pharmaceuticals International, Inc.

List of Tables

Table 01: Global Market Size (US$ Mn) Forecast, By Drug Class, 2018 to 2033
Table 02: Global Market Size (US$ Mn) Forecast, By Formulation, 2023 to 2033
Table 03: Global Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 to 2033
Table 04: Global Market (US$ Mn) Forecast, By Region, 2018 to 2033
Table 05: North America Market Size (US$ Mn) Forecast, by Drug Class, 2018 to 2033
Table 06: North America Market Size (US$ Mn) Forecast, by Formulation, 2018 to 2033
Table 07: North America Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 to 2033
Table 08: North America Market Size (US$ Mn) Forecast, by Country, 2018 to 2033
Table 09: Europe Market Size (US$ Mn) Forecast, by Drug Class, 2018 to 2033
Table 10: Europe Market Size (US$ Mn) Forecast, by Formulation, 2018 to 2033
Table 11: Europe Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 and 2033
Table 12: Europe Market Size (US$ Mn) Forecast, by Country, 2018 to 2033
Table 13: Asia Pacific Market Size (US$ Mn) Forecast, by Drug Class, 2018 to 2033
Table 14: Asia Pacific Market Size (US$ Mn) Forecast, by Formulation, 2018 to 2033
Table 15: Asia Pacific Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 and 2033
Table 16: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2018 to 2033
Table 17: Latin America Market Size (US$ Mn) Forecast, by Drug Class, 2018 to 2033
Table 18: Latin America Market Size (US$ Mn) Forecast, by Formulation, 2018 to 2033
Table 19: Latin America Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 to 2033
Table 20: Latin America Market Size (US$ Mn) Forecast, by Country, 2018 to 2033
Table 21: Middle East and Africa Market Size (US$ Mn) Forecast, by Drug Class, 2018 to 2033
Table 22: Middle East and Africa Market Size (US$ Mn) Forecast, by Formulation, 2018 to 2033
Table 23: Middle East and Africa Market Size (US$ Mn) Forecast, By Distribution Channel, 2018 and 2033
Table 24: Middle East and Africa Market Size (US$ Mn) Forecast, by Country, 2018 to 2033

List of Figures

Figure 01: Global Market Size (US$ Mn) Forecast, 2018 to 2033
Figure 02: Market Value Share, By Drug Class (2022)
Figure 03: Market Value Share, By Formulation (2022)
Figure 04: Market Value Share By, Distribution Channel (2022)
Figure 05: Market Value Share, By Region (2022)
Figure 06: Porter’s Five Force Analysis
Figure 07: Global Market Value Share Analysis, By Drug Class, 2022 and 2033
Figure 08: Global Proton Pump Inhibitor Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033
Figure 09: Global H2 Antagonist Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033
Figure 10: Global Acid Neutralizer Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033
Figure 11: Market Attractiveness Analysis, By Drug Class
Figure 12: Global Market Value Share Analysis, By Formulation, 2022 and 2033
Figure 13: Global Tablet Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033
Figure 14: Global Liquids Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033
Figure 15: Global Powder Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033
Figure 16: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033
Figure 17: Global Market Attractiveness Analysis, By Formulation
Figure 18: Global Market Value Share Analysis, By Distribution Channel, 2022 and 2033
Figure 19: Global Hospital Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033
Figure 20: Global Retail Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033
Figure 21: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2033
Figure 22: Global Market Attractiveness Analysis, By Distribution Channel
Figure 23: Global Market Value Share, By Region, 2022 and 2033
Figure 24: Global Market Attractiveness Analysis, By Region Type
Figure 25: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018 to 2033
Figure 26: North America Market Attractiveness Analysis, By Country
Figure 27: North America Market Value Share Analysis, By Drug Class, 2022 and 2033
Figure 28: North America Market Value Share Analysis, By Formulation, 2022 and 2033
Figure 29: North America Market Value Share Analysis, By Distribution Channel, 2022 and 2033
Figure 30: North America Market Value Share Analysis, By Country, 2022 and 2033
Figure 31: North America Market Attractiveness Analysis, By Drug Class
Figure 32: North America Market Attractiveness Analysis, By Formulation
Figure 33: North America Market Attractiveness Analysis, By Distribution Channel
Figure 34: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018 to 2033
Figure 35: Europe Market Attractiveness Analysis, By Country
Figure 36: Europe Market Value Share Analysis, By Drug Class, 2022 and 2033
Figure 37: Europe Market Value Share Analysis, By Formulation, 2022 and 2033
Figure 38: Europe Market Value Share Analysis, By Distribution Channel, 2022 and 2033
Figure 39: Europe Market Value Share Analysis, By Country, 2022 and 2033
Figure 40: Europe Market Attractiveness Analysis, By Drug Class
Figure 41: Europe Market Attractiveness Analysis, By Formulation
Figure 42: Europe Market Attractiveness Analysis, By Distribution Channel
Figure 43: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018 to 2033
Figure 44: Asia Pacific Market Attractiveness Analysis, By Country
Figure 45: Asia Pacific Market Value Share Analysis, By Drug Class, 2022 and 2033
Figure 46: Asia Pacific Market Value Share Analysis, By Formulation, 2022 and 2033
Figure 47: Asia Pacific Market Value Share Analysis, By Distribution Channel, 2022 and 2033
Figure 48: Asia Pacific Market Value Share Analysis, By Country, 2022 and 2033
Figure 49: Asia Pacific Market Attractiveness Analysis, By Drug Class
Figure 50: Asia Pacific Market Attractiveness Analysis, By Formulation
Figure 51: Asia Pacific Market Attractiveness Analysis, By Distribution Channel
Figure 52: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018 to 2033
Figure 53: Latin America Market Attractiveness Analysis, By Country
Figure 54: Latin America Market Value Share Analysis, By Drug Class, 2022 and 2033
Figure 55: Latin America Market Value Share Analysis, By Formulation, 2022 and 2033
Figure 56: Latin America Market Value Share Analysis, By Distribution Channel, 2022 and 2033
Figure 57: Latin America Market Value Share Analysis, By Country, 2022 and 2033
Figure 58: Latin America Market Attractiveness Analysis, By Drug Class
Figure 59: Latin America Market Attractiveness Analysis, By Formulation
Figure 60: Latin America Market Attractiveness Analysis, By Distribution Channel
Figure 61: Middle East and Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2018 to 2033
Figure 62: Middle East and Africa Market Attractiveness Analysis, By Country
Figure 63: Middle East and Africa Market Value Share Analysis, By Drug Class, 2022 and 2033
Figure 64: Middle East and Africa Market Value Share Analysis, By Formulation, 2022 and 2033
Figure 65: Middle East and Africa Market Value Share Analysis, By Distribution Channel, 2022 and 2033
Figure 66: Middle East and Africa Market Value Share Analysis, By Country, 2022 and 2033
Figure 67: Middle East and Africa Market Attractiveness Analysis, By Drug Class
Figure 68: Middle East and Africa Market Attractiveness Analysis, By Formulation
Figure 69: Middle East and Africa Market Attractiveness Analysis, By Distribution Channel
Figure 70: AstraZeneca, Breakdown of Net Sales (%), by Region, 2022
Figure 71: AstraZeneca, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 72: Bayer AG, Breakdown of Net Sales (%), by Region, 2022
Figure 73: Bayer AG, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 74: Boehringer Ingelheim, Break down of Net Sales (%), by Region, 2022
Figure 75: Boehringer Ingelheim, Revenue (US$ Mn) & Y-o-Y Growth (%), 2018 to 2022
Figure 76: Dr. Reddy’s, Breakdown of Net Sales (%), by Region, 2022
Figure 77: Dr. Reddy’s, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 78: GlaxoSmithKline, Breakdown of Net Sales (%), by Region, 2022
Figure 79: GlaxoSmithKline, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 80: Johnson & Johnson, Break down of Net Sales (%), by Region, 2022
Figure 81: Johnson & Johnson, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 82: Pfizer Inc., Breakdown of Net Sales (%), by Region, 2022 (%)
Figure 83: Pfizer Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 84: P&G, Breakdown of Net Sales (%), by Region, 2022
Figure 85: P&G, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 86: Reckitt Benckiser, Breakdown of Net Sales (%), by Region, 2022
Figure 87: Reckitt Benckiser, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 88: Sanofi, Breakdown of Net Sales (%), by Region, 2022
Figure 89: Sanofi, Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022
Figure 90: Breakdown of Net Sales (%), by Region, 2022
Figure 91: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014 to 2022
Figure 92: Takeda Pharmaceutical, Break down of Net Sales (%), by Region, 2022
Figure 93: Takeda Pharmaceutical, Revenue (US$ Bn) & Y-o-Y Growth (%), 2018 to 2022
Figure 94: Valeant Pharmaceuticals International, Inc., Break down of Net Sales (%), by Region, 2022
Figure 95: Valeant Pharmaceuticals International, Inc., Revenue (US$ Bn) & Y-o-Y Growth (%), 2018 to 2022